Simulated presence therapy for dementia: A systematic review protocol

BMJ Open

Volumn 6, Issue 5, 2016, Pages

  Abraha, Iosief ^a   Rimland, Joseph M ^a   Lozano Montoya, Isabel ^b   Dell'Aquila, Giuseppina ^a   Vélez Díaz Pallarés, Manuel ^b   Trotta, Fabiana M ^b   Cherubini, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRESSION; AGITATION; APATHY; COHORT ANALYSIS; DATA BASE; DEMENTIA; DEPRESSION; DISEASE REGISTRY; HUMAN; IRRITABILITY; OUTCOME ASSESSMENT; PATIENT CARE; PREVALENCE; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SIMULATED PRESENCE THERAPY; SLEEP DISORDER; THERAPY EFFECT; TREATMENT INDICATION; BIBLIOGRAPHIC DATABASE; COMPLICATION; LITERATURE; MENTAL DISEASE; METHODOLOGY;

DATABASES, BIBLIOGRAPHIC; DEMENTIA; HUMANS; MENTAL DISORDERS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC;

EID: 84971264999     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-011007     Document Type: Review

References (49)

1. Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013;9:63-75 e2.
2. Thies W, Bleiler L. 2012 Alzheimer's disease facts and figures. Alzheimers Dement 2012;8:131-68.
3. Wimo A, Jönsson L, Bond J, et al. The worldwide economic impact of dementia 2010. Alzheimers Dement 2013;9:1-11 e3.
4. Cherubini A, Ruggiero C, Dell'Aquila G, et al. Underrecognition and undertreatment of dementia in Italian nursing homes. J Am Med Dir Assoc 2012;13:759.e7-13.
5. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol 2012;3:73.
6. Borson S, Raskind MA. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 1997;48(Suppl 6):S17-24.
7. Clyburn LD, Stones MJ, Hadjistavropoulos T, et al. Predicting caregiver burden and depression in Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci 2000;55:S2-13.
8. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ 2015;350:h369.
9. Van Den Wijngaart MA, Vernooij-Dassen MJ, Felling AJ. The influence of stressors, appraisal and personal conditions on the burden of spousal caregivers of persons with dementia. Aging Ment Health 2007;11:626-36.
10. Kunik ME, Snow AL, Davila JA, et al. Causes of aggressive behavior in patients with dementia. J Clin Psychiatry 2010;71:1145-52.
11. Lyketsos CG. Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. Int Psychogeriatr 2007;19:409-20.
12. Spalletta G, Musicco M, Padovani A, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. Am J Geriatr Psychiatry 2010;18:1026-35.
13. Steinberg M, Shao H, Zandi P, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry 2008;23:170-7.
14. Savva GM, Zaccai J, Matthews FE, et al. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. Br J Psychiatry 2009;194:212-19.
15. Lopez OL, Becker JT, Chang YF, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. Am J Psychiatry 2013;170:1051-8.
16. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608.
17. Stern Y, Albert M, Brandt J, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 1994;44:2300-7.
18. Abraha I, Cruz-Jentoft A, Soiza RL, et al. Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: the SENATOR-ONTOP systematic review protocol. BMJ Open 2015;5:e007488.
19. Woods RT, Bruce E, Edwards RT, et al. Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol. Trials 2009;10:64.
20. Zetteler J. Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis. Aging Ment Health 2008;12:779-85.
21. Neal M, Barton Wright P. Validation therapy for dementia. Cochrane Database Syst Rev 2003;(3):CD001394.
22. Peng WN, Zhao H, Liu ZS, et al. Acupuncture for vascular dementia. Cochrane Database Syst Rev 2007;(2):CD004987.
23. Forrester LT, Maayan N, Orrell M, et al. Aromatherapy for dementia. Cochrane Database Syst Rev 2014;2:CD003150.
24. Forbes D, Blake CM, Thiessen EJ, et al. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database Syst Rev 2014;2:CD003946.
25. Viggo Hansen N, Jørgensen T, Ørtenblad L. Massage and touch for dementia. Cochrane Database Syst Rev 2006;(4):CD004989.
26. Vink AC, Birks JS, Bruinsma MS, et al. Music therapy for people with dementia. Cochrane Database Syst Rev 2004;(3):CD003477.
27. Chung JC, Lai CK, Chung PM, et al. Snoezelen for dementia. Cochrane Database Syst Rev 2002;(4):CD003152.
28. Cameron M, Lonergan E, Lee H. Transcutaneous electrical nerve stimulation (TENS) for dementia. Cochrane Database Syst Rev 2003;(3):CD004032.
29. Moniz Cook ED, Swift K, James I, et al. Functional analysis-based interventions for challenging behaviour in dementia. Cochrane Database Syst Rev 2012;2:CD006929.
30. Forbes D, Thiessen EJ, Blake CM, et al. Exercise programs for people with dementia. Cochrane Database Syst Rev 2013;12:CD006489.
31. O'Connor DW, Ames D, Gardner B, et al. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr 2009;21:241-51.
32. Woods P, Ashley J. Simulated presence therapy: using selected memories to manage problem behaviors in Alzheimer's disease patients. Geriatr Nurs 1995;16:9-14.
33. Garland K, Beer E, Eppingstall B, et al. A comparison of two treatments of agitated behavior in nursing home residents with dementia: simulated family presence and preferred music. Am J Geriatr Psychiatry 2007;15:514-21.
34. Miesen Bère ML. Alzheimer's disease, the phenomenon of parent fixation and bowlby's attachment theory. Int J Geriatr Psychiatry 1993;8:147-53.
35. Peak JS, Cheston RI. Using simulated presence therapy with people with dementia. Aging Ment Health 2002;6:77-81.
36. Algase DL, Beck C, Kolanowski A, et al. Need-driven dementia-compromised behavior: an alternative view of disruptive behavior. Am J Alzheimers Dis Other Demen 1996;11:10-19.
37. Smith M, Gerdner LA, Hall GR, et al. History, development, and future of the progressively lowered stress threshold: a conceptual model for dementia care. J Am Geriatr Soc 2004;52:1755-60.
38. Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012;366:893-903.
39. Katz I, de Deyn PP, Mintzer J, et al. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry 2007;22:475-84.
40. Olin J, Schneider L. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev 2002;(3):CD001747.
41. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12.
42. Opie J, Rosewarne R, O'Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Aust N Z J Psychiatry 1999;33:789-99.
43. Leendertse AJ, Van Den Bemt PM, Poolman JB, et al. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health 2011;14:34-40.
44. Rottenkolber D, Schmiedl S, Rottenkolber M, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf 2011;20:626-34.
45. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration, 2011. http://wwwcochranehandbookorg2011
46. Deeks J, Higgins J, Altman D. Chapter 9: analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews. Wiley-Blackwell, 2011:243-96.
47. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011;64:401-6.
48. Schünemann HJ, Oxman AD, Higgins JPT, et al. Chapter 11: presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. http://wwwcochrane-handbookorg (accessed Mar 2015).
49. Schünemann HJ, Oxman AD, Vist GE, et al. Chapter 12: interpreting results and drawing conclusions. In: Higgins JPT, Green S, eds. Cochrane handbook of systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. http://wwwcochranehandbookorg(accessed Mar 2015).